| 2mtk |
NMR structure of the III-IV-V three-way junction from the VS ribozyme and identification of magnesium-binding sites using paramagnetic relaxation enhancement |
21 |
21 |
SOLUTION NMR |
| 2mtl |
Solution NMR Structure of De novo designed FR55, Northeast Structural Genomics Consortium (NESG) Target OR109 |
20 |
20 |
SOLUTION NMR |
| 2mtm |
NMR structure of RCB-1 peptide |
15 |
15 |
SOLUTION NMR |
| 2mtn |
Solution structure of MLL-IBD complex |
20 |
20 |
SOLUTION NMR |
| 2mto |
Non-reducible analogues of alpha-conotoxin RgIA: [2,8]-cis dicarba RgIA |
20 |
20 |
SOLUTION NMR |
| 2mtp |
The structure of Filamin repeat 21 bound to integrin |
20 |
20 |
SOLUTION NMR |
| 2mtq |
Solution Structure of a De Novo Designed Peptide that Sequesters Toxic Heavy Metals |
20 |
20 |
SOLUTION NMR |
| 2mts |
Three-Dimensional Structure and Interaction Studies of Hepatitis C Virus p7 in 1,2-Dihexanoyl-sn-glycero-3-phosphocholine by Solution Nuclear Magnetic Resonance |
10 |
10 |
SOLUTION NMR |
| 2mtt |
Non-reducible analogues of alpha-conotoxin RgIA: [3,12]-cis dicarba RgIA |
20 |
20 |
SOLUTION NMR |
| 2mtu |
Non-reducible analogues of alpha-conotoxin RgIA: [3,12]-trans dicarba RgIA |
20 |
20 |
SOLUTION NMR |
| 2mtv |
Solution Structure of the YTH Domain of YT521-B in complex with N6-Methyladenosine containing RNA |
20 |
20 |
SOLUTION NMR |
| 2mtw |
Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DR 1*03 molecules induces antibody production and protection |
1 |
1 |
SOLUTION NMR |
| 2mtx |
Protection against experimental P. falciparum malaria is associated with short AMA-1 peptide analogue alpha-helical structures |
1 |
1 |
SOLUTION NMR |
| 2mty |
3D structure determination of STARP peptides implicated in P. falciparum Invasion of hepatic cells |
1 |
1 |
SOLUTION NMR |
| 2mtz |
Haddock model of Bacillus subtilis L,D-transpeptidase in complex with a peptidoglycan hexamuropeptide |
5 |
5 |
SOLID-STATE NMR |
| 2mu0 |
Solution structure of a putative arsenate reductase from Brucella melitensis. Seattle Structural Genomics Center for Infectious Disease target BrabA.00073.a |
20 |
20 |
SOLUTION NMR |
| 2mu1 |
NMR structure of the core domain of NP_346487.1, a putative phosphoglycolate phosphatase from Streptococcus pneumoniae TIGR4 |
20 |
20 |
SOLUTION NMR |
| 2mu2 |
NMR structure of the cap domain of NP_346487.1, a putative phosphoglycolate phosphatase from Streptococcus pneumoniae TIGR4 |
20 |
20 |
SOLUTION NMR |
| 2mu3 |
Spider wrapping silk fibre architecture arising from its modular soluble protein precursor |
20 |
20 |
SOLUTION NMR |
| 2mu4 |
Structure of F. tularensis Virulence Determinant |
20 |
20 |
SOLUTION NMR |
| 2mu6 |
3D structure determination of STARP peptides implicated in P. falciparum Invasion of hepatic cells |
1 |
1 |
SOLUTION NMR |
| 2mu7 |
Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malaria |
1 |
1 |
SOLUTION NMR |
| 2mu8 |
Residues belonging the n-terminal region derived of merozoite surface protein-2 of plasmodium falciparum |
1 |
1 |
SOLUTION NMR |
| 2mu9 |
Changing ABRA protein peptide to fit the HLA-DR B1*0301 molecule renders it protection-inducing |
21 |
21 |
SOLUTION NMR |
| 2mua |
Shifting the Polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Breaking Conserved Antigens |
1 |
1 |
SOLUTION NMR |
| 2mub |
Solution structure of the analgesic sea anemone peptide APETx2 |
20 |
20 |
SOLUTION NMR |
| 2muc |
MUCONATE CYCLOISOMERASE VARIANT F329I |
1 |
1 |
X-RAY DIFFRACTION |
| 2mud |
Structural modifications to a high-activity binding peptide located whitin the PfEMP1 NTS domain induce protection against P. falciparum malaria in Aotus monkeys |
29 |
29 |
SOLUTION NMR |
| 2mue |
Structure Immunogenicity and Protectivity Relationship for the 1585 Malarial Peptide and Its Substitution Analogues |
1 |
1 |
SOLUTION NMR |
| 2muf |
Binding activity, structure, and immunogenicity of synthetic peptides derived from Plasmodium falciparum CelTOS and TRSP proteins |
1 |
1 |
SOLUTION NMR |
| 2mug |
Protective cellular immunity against P. falciparum malaria merozoite is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex |
22 |
22 |
SOLUTION NMR |
| 2muh |
High-resolution NMR structure of the protegrin-2 docked to DPC Micelles |
20 |
20 |
SOLUTION NMR |
| 2mui |
Solution structure of the AlgH protein from Pseudomonas aeruginosa, PA0405, UPF0301 |
20 |
20 |
SOLUTION NMR |
| 2muj |
Plasmodium falciparum SERA protein peptide analogues having short helical regions induce protection against malaria |
13 |
13 |
SOLUTION NMR |
| 2muk |
1H, 13C, and 15N Chemical Shift Assignments for AUX/IAA17 |
20 |
20 |
SOLUTION NMR |
| 2mul |
Solution Structure of the UBM1 domain of human HUWE1/ARF-BP1 |
20 |
20 |
SOLUTION NMR |
| 2mum |
Solution structure of the PHD domain of Yeast YNG2 |
20 |
20 |
SOLUTION NMR |
| 2mun |
Solution structure of mu-SLPTX3-Ssm6a |
25 |
25 |
SOLUTION NMR |
| 2muq |
Solution Structure of the Human FAAP20 UBZ |
10 |
10 |
SOLUTION NMR |
| 2mur |
Solution Structure of the Human FAAP20 UBZ-Ubiquitin Complex |
10 |
10 |
SOLUTION NMR |
| 2mus |
HADDOCK calculated model of LIN5001 bound to the HET-s amyloid |
4 |
4 |
SOLUTION NMR |
| 2mut |
Solution structure of the F231L mutant ERCC1-XPF dimerization region |
20 |
20 |
SOLUTION NMR |
| 2muu |
The Proteolytic Activity of Ubiquitin-specific Protease 28 Is Modulated by the N-terminal Domain |
14 |
14 |
SOLUTION NMR |
| 2muv |
NOE-based model of the influenza A virus M2 (19-49) bound to drug 11 |
20 |
20 |
SOLUTION NMR |
| 2muw |
NOE-based model of the influenza A virus N31S mutant (19-49) bound to drug 11 |
20 |
20 |
SOLUTION NMR |
| 2mux |
SUMO2 non-covalently interacts with USP25 and downregulates its activity |
15 |
15 |
SOLUTION NMR |
| 2muy |
The solution structure of the FtsH periplasmic N-domain |
20 |
20 |
SOLUTION NMR |
| 2muz |
ssNMR structure of a designed rocker protein |
1 |
1 |
SOLUTION NMR |
| 2mv0 |
Solution NMR Structure of Maltose-binding protein from Escherichia coli, Northeast Structural Genomics Consortium (NESG) Target ER690 |
10 |
10 |
SOLUTION NMR |
| 2mv1 |
Solution NMR structure of Human Relaxin-2 |
20 |
20 |
SOLUTION NMR |